... to kidney transplantation, but little is known about access before waitlisting due to the lack of national data on pre-waitlisting measures. The Early Steps to Transplant Access Registry (E-STAR) captures referral and evaluation data in four US regions, including the Ohio River Valley, and this study...

...Hoon Yu; Sung Jin Kim; Yoonjong Bae; Mina Kim; Chan-Young Jung Introduction: Although both patients with kidney failure (KF) receiving hemodialysis (HD) and kidney transplantation (KT) recipients (KTRs) have a high risk of bladder cancer, how this risk changes in the transition from dialysis to KT...

...Jaeyun Lee; Chung Hee Baek; Soon Bae Kim; Chan-Young Jung Introduction: Although studies have suggested that metabolic risk profiles are prognostic factors in kidney transplantation recipients (KTRs), the prognostic value of fatty liver, a known surrogate of metabolic risk, in KTRs remains...

...Firas F. Alkaff; Audrey Uffing; Gesa Tiller; Rosa G.M. Lammerts; Marius C. van den Heuvel; Ingeborg M. Bajema; Mohamed R. Daha; Jacob van den Born; Stefan P. Berger Introduction: Recurrent IgA deposition is common after kidney transplantation. However, it is difficult to define whether IgA...

...Elena Rodriguez-Sanchez; Jennifer Aceves-Ripoll; Elisa Mercado-García; José A. Navarro-García; Amado Andrés; José M. Aguado; Julián Segura; Luis M. Ruilope; Mario Fernández-Ruiz; Gema Ruiz-Hurtado Introduction: Oxidative stress has been implicated in complications after kidney transplantation (KT...

... whether higher serum activin levels were associated with poor allograft outcomes in patients with kidney transplantation (KT). Methods: A total of 860 KT patients from KNOW-KT (Korean Cohort Study for Outcome in Patients with Kidney Transplantation) were analyzed. We measured serum activin levels pre-KT...

...Tai Yeon Koo; Juhan Lee; Yonggu Lee; Hyung Woo Kim; Beom Seok Kim; Kyu Ha Huh; Jaeseok Yang Introduction: ABO-incompatible (ABOi) living donor kidney transplantation (LDKT) is considered only for patients who do not have an ABO-compatible (ABOc) LD. Therefore, a clinically practical question...

... for early detection of kidney function decline. We investigated whether fetuin-A could serve as a marker of graft failure in kidney transplant recipients (KTRs). Methods: Data of KTR with a functioning graft ≥1 year that were enrolled in the TransplantLines Food and Nutrition Biobank and cohort study were...

...Hsin-Lin Tsai; Tzu-Ching Lin; Niang-Cheng Lin; Hui-Hsin Yang; Jei-Wen Chang Introduction: Kidney transplant recipients are at an increased risk of fractures, and targeted preventive strategies are needed. Therefore, in this retrospective cohort study, we investigated a large population-based cohort...

...Mayuko Hori; Hiroshi Takahashi; Chika Kondo; Yutaka Matsuoka; Makoto Tsujita; Morikuni Nishihira; Kazuharu Uchida; Asami Takeda; Kunio Morozumi; Shoichi Maruyama Introduction: Sarcopenia and osteoporosis are highly prevalent among kidney transplant recipients (KTRs). Although osteoporosis is known...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Alport syndrome Cardiovascular outcomes Collagen Genetics Kidney transplantation...

...Ido Druckmann; Hila Yashar; Doron Schwartz; Idit F. Schwartz; Yaacov Goykhman; Orit Kliuk Ben-Bassat; Roni Baruch; Roie Tzadok; Moshe Shashar; Keren Cohen-Hagai; Ayelet Grupper Introduction: Kidney transplantation is the treatment of choice for patients with renal failure. It is crucial to select...

... troponin I (cTNI) has demonstrated its predicting value in survival after kidney transplant. Growth differentiation factor 15 (GDF-15) is a biomarker currently studied as a predictor of mortality and cardiovascular events (CVE) in different scenarios. The aim of this study was to compare the utility...

... measurements, mGFR by iohexol-clearance and kidney allograft biopsies were obtained from kidney transplant recipients (KTRs) included in the Omega-3 fatty acids in Renal Transplantation (ORENTRA) trial at 8 weeks (baseline) and at 1 year after transplantation (end of study). Associations were analyzed...

...Maria Korogiannou; Pantelis Sarafidis; Marieta P. Theodorakopoulou; Maria-Eleni Alexandrou; Efstathios Xagas; Ioannis N. Boletis; Smaragdi Marinaki Introduction: Hypertension is the most prominent risk factor in kidney transplant recipients (KTRs). No study so far assessed in parallel...

... kidney function. The present randomized controlled trial examines the effect of prophylactic AV fistula closure on high-output heart failure. Methods: Twenty-eight kidney transplant patients with stable graft function, absence of pre-existing severe cardiac failure, and brachial arterial flow rate...

...) or kidney transplantation (KT). Methods: We leveraged 3 cohorts: 378 adults initiating HD (2008–2012), 4,304 adult KT candidates (2009–2019), and 1,396 KT recipients (2008–2019). The frailty phenotype was measured within 6 months of dialysis initiation, at KT evaluation, and KT admission. Prevalence...

...Beini Lyu; Karen E. Hansen; Margaret R. Jorgenson; Brad C. Astor Background: In the general population, use of proton pump inhibitor (PPI) has been linked to higher risk of osteoporotic fractures. PPI is commonly prescribed in kidney transplant recipients (KTRs). However, the effect of PPI...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Visual Abstract Visual Abstract. Kidney transplantation Living donor Donors...

...Pratik B. Shah; Jennifer L. Ennis; Patrick N. Cunningham; Michelle A. Josephson; Rita L. McGill Background: Within-patient tacrolimus level variability >30% has been shown to be a risk factor for de novo donor-specific antibody formation and death-censored graft failure among kidney transplant...